SYDNEY, Australia — Apomorphine may represent a novel therapeutic agent to reduce the burden of cognitive impairment in patients with Parkinson's disease (PD). Preliminary findings from a study from ...

TORONTO, ONTARIO--(Marketwired - May 15, 2013) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH), a specialty pharmaceutical company developing the only known orally administered (sublingual) formulation ...

Please provide your email address to receive an email when new articles are posted on . Apomorphine sublingual film resulted in greater motor improvement and an increase in responders at earlier time ...

The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for SPN-830, an apomorphine infusion device for the continuous treatment of motor fluctuations ...

Please provide your email address to receive an email when new articles are posted on . Apomorphine may provide relief for patients with Parkinson’s disease during periods of immobility related to ...

Apomorphine subcutaneous infusion is an effective treatment for Parkinson patients whose motor fluctuations are poorly controlled by conventional therapies. This was shown by the large-scale TOLEDO ...

Learn everything you need to know about Apomorphine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

The NDA for SPN-830 is supported by data from an extensive development program that includes the phase 3 TOLEDO study and a supportive open-label study. The New Drug Application (NDA) for SPN-830 ...

May 20, 2004 — Daily sublingual (SL) apomorphine may improve the sexual life of premenopausal women with sexual arousal disorder and recurrent hypoactive sexual disorder, according to results of a ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson's disease, Supernus Pharmaceuticals announced on Tuesday. The ...

Lal et al 1 showed in a placebo-controlled double-blind study on healthy volunteers that apomorphine injected subcutaneously (s.c) was able to induce erection. However, side effects limited its ...